Synthetic heparin

Current Opinion in Pharmacology

Volumn 12, Issue 2, 2012, Pages 217-219

  Linhardt, Robert J ^a   Liu, Jian ^b  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ULTRA LOW MOLECULAR WEIGHT HEPARIN; UNCLASSIFIED DRUG;

BLEEDING; BLOOD CLOTTING DISORDER; DEEP VEIN THROMBOSIS; DRUG BIOAVAILABILITY; DRUG CONTAMINATION; DRUG HALF LIFE; DRUG MANUFACTURE; DRUG MARKETING; DRUG SYNTHESIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY;

ANIMALS; ANTICOAGULANTS; BIOENGINEERING; HEPARIN; HUMANS;

EID: 84862778031     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2011.12.002     Document Type: Note

References (15)

1. R.J. Linhardt Heparin: structure and activity J Med Chem 46 2003 2551 2554
2. R.J. Linhardt, and N.S. Gunay Production and chemical processing of low molecular weight heparins Semin Thrombos Hemostas 25 1999 5 16
3. Y. Xu, S. Masuko, M. Takieddin, H. Xu, R. Liu, J. Jing, S. Mousa, R.J. Linhardt, and J. Liu Chemoenzymatic synthesis of structurally homogeneous ultra-low molecular weight heparins Science 334 2011 498 501
4. P. Sinaÿ, J.-C. Jacquinet, M. Petitou, P. Duchaussoy, I. Lederman, J. Choay, and G. Torri Total synthesis of a heparin pentasaccharide fragment having high affinity for antithrombin III Carbohydr Res 132 1984 C5 C9
5. H. Liu, Z. Zhang, and R.J. Linhardt Lessons learned from the contamination of heparin Nat Prod Rep 26 2009 313 321
6. U. Lindahl, M. Kusche-Gullberg, and L. Kjellén Regulated diversity of heparan sulfate J Biol Chem 273 1998 24979 24982
7. J.D. Esko, and S.B. Selleck Order out of chaos: assembly of ligand binding sites in heparan sulfate Annu Rev Biochem 71 2002 435 471
8. S. Peterson, A. Frick, and J. Liu Design of biologically active heparan sulfate and heparin using an enzyme-based approach Nat Prod Rep 26 2009 610 627
9. Z. Zhang, S.A. McCallum, J. Xie, L. Nieto, F. Corzana, J. Jiménez-Barbero, M. Chen, J. Liu, and R.J. Linhardt Solution structures of chemoenzymatically synthesized heparin and its precursors J Am Chem Soc 130 2008 12998 13007
10. B. Kuberan, M.Z. Lech, D.L. Beeler, Z.L. Wu, and R.D. Rosenberg Enzymatic synthesis of antithrombin III-binding heparan sulfate pentasaccharide Nat Biotechnol 21 2003 1343 1346
11. U. Lindahl, J.P. Li, M. Kusche-Gullberg, M. Salmivirta, S. Alaranta, T. Veromaa, J. Emeis, I. Roberts, C. Taylor, and P. Oreste Generation of "neoheparin" from E. coli K5 capsular polysaccharide J Med Chem 48 2005 349 352
12. T.A. Kane, C.L. White, and P.L. DeAngelis Functional characterization of PmHS1, a Pasteurella multocida heparosan synthase J Biol Chem 281 2006 33192 33197
13. Z. Wang, B. Yang, Z. Zhang, M. Ly, M. Takieddin, S. Mousa, J. Liu, J.S. Dordick, and R.J. Linhardt Control of the heparosan N-deacetylation leads to an improved bioengineered heparin Appl Microbiol Biotechnol 91 2011 91 99
14. M.D. Burkart, M. Izumi, E. Chapman, C.H. Lin, and C.H. Wong Regeneration of PAPS for the enzymatic synthesis of sulfated oligosaccharides J Org Chem 65 2000 5565 5574
15. X. Zhou, K. Chandarajoti, T.Q. Pham, R. Liu, and J. Liu Expression of heparan sulfate sulfotransferases in Kluyveromyces lactis and preparation of 3′-phosphoadenosine-5′-phosphosulfate Glycobiology 21 2011 771 780